Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.21
- Piotroski Score 3.00
- Grade Buy
- Symbol (HLN)
- Company Haleon plc
- Price $9.60
- Changes Percentage (0.58%)
- Change $0.06
- Day Low $9.51
- Day High $9.62
- Year High $10.80
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
- Last Earnings 08/01/2024
- Ex-Dividend for 5/16 Dividend 08/16/2024
- Dividend Payable 09/19/2024
- Today N/A
- Next Earnings (Estimated) 03/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $9.15
- High Stock Price Target $9.15
- Low Stock Price Target $9.15
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.30
- Trailing P/E Ratio 28.4
- Forward P/E Ratio 28.4
- P/E Growth 28.4
- Net Income $1.05 B
Income Statement
Quarterly
Annual
Latest News of HLN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Haleon plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Haleon plc released third-quarter results, showing revenue slightly below expectations but profits exceeding forecasts. Analysts predict a 2.2% revenue increase and a 39% rise in earnings per share by...
By Yahoo! Finance | 4 days ago -
Analysts Are Updating Their Haleon plc (LON:HLN) Estimates After Its Half-Yearly Results
Haleon plc (LON:HLN) shares rose 4.3% after releasing its interim results, meeting analyst estimates. Forecasts show a 31% increase in EPS for 2024....
By Yahoo! Finance | 3 months ago -
Haleon (LON:HLN) Is Looking To Continue Growing Its Returns On Capital
To identify a stock with long-term growth potential, look for increasing Return on Capital Employed (ROCE) and capital employed. Haleon (LON:HLN) shows promising trends with a rising ROCE and stable c...
By Yahoo! Finance | 3 months ago
